Antiplatelet therapy and the risk of ischemic and hemorrhagic complications associated with Pipeline embolization of cerebral aneurysms: a systematic review and pooled analysis.
Hamidreza SaberRiyad Y KherallahMohamad O HadiedShaghayegh KazemlouParthasarathi ChamirajuSandra NarayananPublished in: Journal of neurointerventional surgery (2018)
High-dose ASA therapy and clopidogrel treatment for at least 6 months were associated with a reduced incidence of ischemic events, without affecting the risk of hemorrhagic events.
Keyphrases
- antiplatelet therapy
- acute coronary syndrome
- percutaneous coronary intervention
- high dose
- cerebral ischemia
- risk factors
- ischemia reperfusion injury
- subarachnoid hemorrhage
- low dose
- coronary artery disease
- stem cell transplantation
- atrial fibrillation
- brain injury
- replacement therapy
- mesenchymal stem cells
- cell therapy
- smoking cessation